FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Healthcare Apps Need Strong Privacy, Security: Attorney

[ Price : $8.95]

Attorney Alaap Shah says that technology companies planning to market healthcare apps need to be sure they have adequate privacy a...

FDA Permanently Debars Sharp

[ Price : $8.95]

Federal Register Notice: FDA permanently debars Lisa Jean Sharp from providing services to any person with an approved or pending ...

Workshop on Glaucoma Imaging Devices

[ Price : $8.95]

Federal Register Notice: FDA will co-sponsor a public workshop 10/5 on glaucoma imaging devices.

FDA Grants Final OK for Lupins Generic Lexapro

[ Price : $8.95]

FDA grants final approval to Lupin Pharmaceuticals for its escitalopram tablets, a generic of Forest Labs Lexapro.

FDA Clears Access Scientific Peripheral IV Catheter

[ Price : $8.95]

FDA grants 510(k) clearance to Access Scientific for the 4Fr Nanopuncture Powerwand, a power-injectable IV catheter cleared to sta...

Ads for Switched Drugs Have Less Risk Info

[ Price : $8.95]

Researchers say that ads for drugs that have been switched to OTC have less risk information than ads for the same drugs when they...

CDRH Aggressively Pursues 'Single Audit Program'

[ Price : $8.95]

Office of Compliance director Steve Silverman updates a PDA conference session on the Centers single audit program where a third-p...

FDA Clears GenMark Diagnostics

[ Price : $8.95]

FDA clears a GenMark Diagnostics 510(k) application for its eSensor Respiratory Virus Panel, indicated to detect and differentiate...

FDA Approves Prostate Cancer Imaging Agent

[ Price : $8.95]

FDA approves Choline C 11 injection for use in detecting recurrent prostate cancer through PET scans.

Transcept Pharma Begins Phase 2 OCD Study

[ Price : $8.95]

Transcept Pharmaceuticals completes enrollment in a Phase 2 clinical trial evaluating TO-2061 (ondansetron) as adjunctive therapy ...